Multiprévention Competitors

ProHealth was born out of one man's quest for better health. In 1981 Rich Carson discovered he had a chronic illness. He began to research, experiment and develop relationships with health care practitioners to further his own health, and became determined to offer others the same resources and information. He founded ProHealth in 1988 and remains intimately involved in the research and development of the company's products. You'll find a wealth of information here, including the latest research and treatment news, exclusive interviews and live chats with leading physicians, information on traditional and alternative treatment methodologies, and solid advice about symptom control. Our library offers thousands of articles on everything from Alzheimer's to Zinc and is continually updated. In addition, you can sign up for Healthwatch, our free monthly e-newsletter, which will bring the latest health news right to your inbox. Research is the key to finding cures for Chronic Fatigue Syndrome (ME/CFS), Fibromyalgia (FM), and other chronic conditions. Thus ProHealth both donates a portion of its profits and raises funds from other sources in order to further such research. Since 1988, ProHealth has raised and donated over $3 million to organizations focused on finding effective treatments, and one day perhaps cures, for these ailments, and to organizations involved in health advocacy.

Futura's innovation strategy applies advanced science to develop products with compelling commercial potential using our advanced proprietary transdermal technology. Based in Surrey, UK, the company's shares trade on the AIM market of the London Stock Exchange. Futura's development pipeline focuses on sexual healthcare and pain relief management and we are evaluating further therapeutic opportunities as potential additions to the pipeline. Futura is gaining recognition within the pharmaceutical industry for its strengths in transdermal drug delivery technology. We have a number of relationships with key players.